STS. A. Tarasiuk

S. A. Tarasiuk

*This is an algorithmically generated author record based on publicly available information.

S. A. Tarasiuk has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Фертильність жінок старшого репродуктивного віку. Взаємозв’язок фертильності жінок старшого репродуктивного віку та аутофагії

    by О. Л. Льовкіна, С. А. Тарасюк, І. В. Пролигіна, О. А. Мунтян, І. В. Олексієнко

    Загальновідомо, що жіноча репродуктивна здатність знижується протягом четвертого десятиліття життя через вікові зміни якості та кількості ооцитів. У роботі проведено систематичний огляд та метааналіз іноземної та вітчизняної літератури за вказаною тематикою, розміщені в наукометричних базах Scopus, PubMed та інших виданнях із використанням описового, бібліосемантичного та статистичного методів. Попри нейроендокринні та маткові чинники, чітко визначено, що яєчники та фолікули відіграють основну роль у репродуктивному старінні. Функція яєчників досягає свого піку у віці приблизно від 20 до 30 років, і починає знижуватися після 30-річчя. У старшому репродуктивному віці (вік≥35 років), спостерігаємо високий рівень безпліддя, викиднів та трисомічних вагітностей. У цієї групи пацієнток буде спостерігатися знижений оваріальний резерв паралельно зі слабкою реакцією яєчників. Вважається, що гормональні зміни, які відбуваються з віком, негативно впливають на фертильність жінок старшого репродуктивного віку. Зв'язок між аутофагією та жіночою фертильністю отримав знаходиться в центрі уваги упродовж останніх років. Аутофагія вливає на низку репродуктивних процесів, зокрема розвиток яйцеклітин, фолікулогенез та імплантацію ембріона. Попри значний прогрес у розумінні цієї проблеми все ще існує декілька невирішених питань щодо складної взаємодії між аутофагією та жіночою фертильністю. Розробка терапевтичних стратегій для уповільнення старіння яєчників вимагає всебічного розуміння клітинних компонентів, молекулярних властивостей та їхніх просторово-часових змін.

  • Open Access

    Features of the use of combined oral contraceptives for the correction of premenstrual syndrome

    by O. L. Lovkina, S. A. Tarasiuk, O. A. Muntyan

    Annotation. Premenstrual syndrome (PMS) is a set of cognitive, physical, and affective symptoms that occur during the luteal phase of the menstrual cycle and disappear at the beginning of menstruation. Its more severe variant is premenstrual dysphoric disorder (PMDD). The aim of the work is to investigate the effects of combined oral contraceptives and their effectiveness and safety for the correction of PMS and PMDD. A retrospective analysis of the scientific literature was carried out using the following sources: PubMed, ReseachGate, Science Direct, Web of Science, Cochrane. The majority of publications published in the last five years (2019-2024) were selected for the study. Both syndromes are believed to be caused by cyclical changes in progesterone production. Combined oral contraceptives (COCs) are considered one of the treatment options for PMS and PMDD, as the drugs of this group contain synthetic estradiol and progestin, which have a complex effect on the hypothalamic-pituitary-ovarian system.

  • Open Access

    Profiles of neutrophilic intestinal inflammation and endothelial dysfunction in patients with inflammatory bowel disease

    by I. V. Oleksiienko, I. V. Prolygina, О. L. Lovkina, L. A. Klimas, S. A. Tarasiuk, S. V. Prokopenko, S. I. Semenenko

    Annotation. The high level of perinatal pathology of placental genesis, determined by inflammatory bowel diseases (IBD), determines the relevance of the conducted study. The purpose of the study is to analyze indicators of neutrophilic intestinal inflammation and endothelial dysfunction from the point of view of their participation in the development of perinatal pathology of placental origin in IBD. 40 patients with IBD in stable remission were examined, who constituted the clinical study group and 30 practically healthy women of the control group. The following were determined: fecal calprotectin, homocysteine, serum levels of tumor necrosis factor α (TNFα), interleukin-4 (IL4), C-reactive protein (CRP), platelets, fibrinogen, endothelial status was assessed (endothelium-dependent vasodilation (EDV), vascular endothelial growth factor (VEGF) and microalbuminuria (MAU)), laboratory parameters (hemoglobin, erythrocytes, ferritin, ESR). The mean (M) and standard error of the mean (±m) were calculated using the STATISTICA 6.1 (No. AXHR910F374605FA) and MedCalc (version 17.7.7, MedCalc Software) software packages. The obtained results of the study of pregnant women with IBD in remission indicate the development of endothelial dysfunction in them, which was manifested by changes in microalbuminuria indicators, the level of vascular endothelial growth factor and the index of endothelium-dependent vasodilation. In addition, an increase in the level of pro-inflammatory cytokines tumor necrosis factor and interleukin-4, as well as homocysteine in the blood serum of such patients was found. Thus, the results of the study can be included as a component of a non-invasive strategy for monitoring patients with inflammatory bowel diseases in remission, to control perinatal complications of placental origin.

  • Open Access

    The potential effect of the COVID-19 pandemic on women’s reproductive health

    by O. L. Lovkina, L. G. Dubas, S. A. Tarasiuk, O. V. Prolygina

    Annotation. A review of the scientific literature related to the problem of the potential effect of the covid-19 pandemic on women's reproductive health is presented. To date, there are various hypotheses of pathogenesis and ways of detecting changes in a woman's reproductive health, which we will consider. In the context of the COVID-19 pandemic, it is likely that menstrual disturbances are a possible consequence of changes in mental health or a direct effect of the virus on the cells of the reproductive system. For example, research findings suggest that women who have experienced COVID-19 have experienced menstrual changes, including changes in the duration, frequency, regularity, and volume of menstruation (increased bleeding and blood clotting), increased dysmenorrhea, and worsening of premenstrual syndrome (PMS). However, the data available today are not reliable enough to draw firm conclusions on this topic. The purpose of our work is to study the potential impact of the COVID-19 pandemic on women's reproductive health. We conducted a systematic literature review and analysis based on PubMed, ScienceDirect, UpToDate, Web of science, and Scopus databases. When searching for information on the prevalence and prevention of reproductive dysfunction in women who have contracted a coronavirus infection, various combinations of the following keywords were used: “Reproductive health”, “COVID-19”, “pandemic”, “menstrual cycle”, “hormones”. When processing the search results, the most recent publications (for the last 5 years) or the latest publications on this issue (regardless of the age) were chosen. The problem of the potential negative impact of the COVID-19 pandemic on women's reproductive health in the practice of gynecologists around the world is becoming more relevant every year, because the study of the consequences of administrative restrictions in the public health system, violations from the mental system, direct and secondary effects is becoming more relevant virus on the reproductive system. Various menstrual changes (duration, frequency, regularity and volume of menstruation), which can cause a negative socio-psychological impact on women. High-quality work of gynecologists, starting with early detection of disorders, diagnostic and treatment tactics can improve a woman’s condition or reveal secondary causes of such changes.


  • Open Access

    Informativeness of laboratory methods of research of pregnant women with chronic inflammatory bowel disease

    by O. V. Bulavenko, I. V. Oleksiienko, I. V. Prolygina, S. V. Balabueva, S. A. Tarasiuk

    Annotation. The aim of the work is to demonstrate the importance of laboratory parameters in pregnant with chronic inflammatory bowel disease. The examined patients were divided into the main group (ulcerative colitis, n=40) and the control group (practically healthy women, n=30). The formation of observation groups was carried out by methods of continuous and selective analysis. The indicators of vasculo-endothelial growth factor (VEGF), serum levels of vitamin D, homocysteine, markers of neutrophilic intestinal inflammation (serum levels of tumor necrosis factor α and interleukin-4 were studied). Database formation and all calculations were performed using the software packages STATISTICA6.1 (№АХХR910F374605FA) and MedCalc (version 17.7.7, MedCalcSoftware). Statistical processing of quantitative data included the calculation of the mean and standard error of the mean (± m) using parametric criteria (in the case of a normal distribution law) or a nonparametric Mann-Whitney test (if the distribution law differs from the normal one). In the analysis of the informativeness of laboratory methods, it was found that women with chronic inflammatory bowel disease were characterized by: increased levels of fecal calprotectin, proinflammatory cytokines TNFα and interleukin-4, homocysteine. The analysis of markers of endothelial dysfunction in pregnant women with COPD was diagnosed with a significant increase in serum levels of vasculo-endothelial growth factor and an increase in microalbuminuria, which allowed to talk about the association of ulcerative colitis with the development of gestational endotheliopathy in such women.

  • Open Access

    Evaluation of clinical efficacy of preventive therapy in pregnant women with ulcerative colitis

    by O. V. Bulavenko, I. V. Oleksiienko, I. V. Prolygina, S. A. Tarasiuk, S. V. Balabueva

    Annotation. “Voluntary childlessness” as a consequence of fear of infertility, doubts about the ability to cope with pregnancy in the presence of the disease, the hereditary nature of the disease and adverse effects on the fetus; improper medication; self-modification or discontinuation of therapy in patients with CIBD (chronic inflammatory bowel disease) are significant not only medical but also social problems that currently remain unresolved. The aim of this work is to provide up-to-date evidence for the optimal diagnosis and treatment of chronic inflammatory bowel disease before conception, during pregnancy and in the postpartum period. A detailed analysis of the social, somatic, gynecological and obstetric history of women with inflammatory bowel disease was performed. The examined patients were divided into the main group (ulcerative colitis) (n=40) and control groups (almost healthy women) (n=30). The first main clinical group underwent prophylactic therapy using a drug containing active folate of the 4th generation "Quatrefolic" (equivalent to 400 μg of folic acid), potassium iodide 1 table. per day and vitamin D 1000 IU per day, starting from the planning stage of pregnancy). The second major clinical group received, in addition to Quatrefolic and potassium iodide, vitamin D 4,000 IU per day during the pre-pregnancy phase and 2,000 IU per day during pregnancy and 1,000 IU per day in cases of placental dysfunction and anemia. The formation of observation groups was carried out by methods of continuous and selective analysis. Statistical processing of research results was performed using the software package Statistica 6.0. The obtained indicators were processed statistically with the determination of the arithmetic mean (M) and the error of the standard deviation (±m), at p<0,05. Risk ratio (RR) and confidence interval (CI) were determined with a given reliable probability p=95%. Comparison of groups by case frequency was performed using the exact Fisher test (two-way criterion). Pregnant women with ulcerative colitis have a better clinical efficacy of preventive therapy using the 4th generation active folate “Quatrefolic” (equivalent to 400 mcg of folic acid) and vitamin D 4000 IU at the pre-pregnancy stage and 2000 IU after pregnancy verification compared with active folate 4th generation “Quatrefolic” (equivalent to 400 mcg of folic acid) and vitamin D 1000 IU.